Remote monitoring: Doomed to let down or an attractive promise?

Autor: Giuseppina Maura Francese, Nadia Ingianni, Andrea Pozzi, Domenico Gabrielli, Carmelo Massimiliano Rao, Annamaria Iorio, Stefania Angela Di Fusco, Laura Cipolletta, Manuela Benvenuto, Damiana Fiscella, Michele Massimo Gulizia, Daniela Benedetto, Fabiana Lucà, Sandro Gelsomino, Massimo Zecchin, Andrea Madeo
Jazyk: angličtina
Rok vydání: 2019
Předmět:
lcsh:Diseases of the circulatory (Cardiovascular) system
Standardization
ASSERT
ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and atrial fibrillation Reduction atrial pacing Trial

COMPAS
COMPArative follow-up Schedule with home monitoring

SUBCLINICAL ATRIAL-FIBRILLATION
Review
030204 cardiovascular system & hematology
TARIFF
Evaluation Registry for Remote Follow-up

PMK
Pacemaker

RM
Remote Monitoring

ISHNE
International Society for Holter and Noninvasive Electrocardiology

0302 clinical medicine
Health care
EXPERT CONSENSUS
Medicine
ESC GUIDELINES
030212 general & internal medicine
HEART-FAILURE HOSPITALIZATIONS
CRT
Cardiac Resynchronization Therapy

CHAMPION
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients

MULTISENSE HF
Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients

IN-TIME
Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function

MoniC
Model Project Monitor Centre

DEFIBRILLATOR
REFORM Trial
Remote Follow-Up for ICD-Therapy in Patients Meeting MADIT II Criteria

OPTILINK-HF
Optimization of Heart Failure Management Using Medtronic OptiVol Fluid Status Monitoring and CareLink Network

ARTESIA
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

Medical emergency
Cardiology and Cardiovascular Medicine
IMPACT
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

Process (engineering)
MEDLINE
Heart failure
MORE-CARE
MOnitoring Resynchronization dEvices and CARdiac patiEnts

03 medical and health sciences
MANAGEMENT
ICD
Implantable Cardioverter Defibrillator

NYHA
New York Heart Association

TRUST
Lumos-T Safely Reduces Routine Office Device Follow-up

Clinical decision
business.industry
Multiparametric Analysis
EHRA
European Heart Rhythm Association

EVOLVO
Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators

Implantable devices
Management model
RM-HF
REmote Monitoring: an evaluation of implantable devices for management of Heart Failure patients

CONNECT
Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision

NOAH
Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes

AHRE
Atrial High Rate Episodes

medicine.disease
Atrial fibrillation
RANDOMIZED-TRIAL
CIED
Cardiac Implantable Electronic Devices

SELENE
Selection of potential predictors of worsening Heart Failure

Clinical trial
RECIPIENTS
PARTNERS HF
Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure

lcsh:RC666-701
IMPLANTABLE ELECTRONIC DEVICES
ECOST
Effectiveness and Cost of ICDs Follow-up Schedule with Telecardiology

FOLLOW-UP
business
Remote telemonitoring
Zdroj: International Journal of Cardiology. Heart & Vasculature
International Journal of Cardiology: Heart & Vasculature, Vol 24, Iss, Pp-(2019)
ISSN: 2352-9067
Popis: Device interrogation and management are time consuming, representing a relevant burden for pacing centers. In several situations, patients' management requires additional follow up visits.Remote Monitoring (RM) allows an optimal recall management and a rapid diagnosis of device or lead failure, without the need of additional in office visits. Further it allows a significant delay reduction between the adverse event and the reaction to the alarm, shortening the time needed to make a clinical decision. A role in risk-predicting patient-related outcomes has also been shown. RM permits detection of the arrhythmia from 1 to 5 months in advance compared to in-office visits. Importantly, by using specific algorithms with multiparametric analysis, RM has been studied as a potential instrument to identify early patients on risk of worsening HF using specific algorithms. Although the use of RM in HF setting remains controversial, it has been proposed to improve HF clinical outcomes and survival in clinical trials. In this sense, RM success could require a standardization of process within a management model, that may involve different health care professionals. In this review, we examine recent advances of RM providing an update of this tool through different clinical scenarios. Keywords: Implantable devices, Heart failure, Atrial fibrillation, Remote telemonitoring
Databáze: OpenAIRE